Posted on January 28, 2016 | By Pharmacy OneSource
January 28, 2016 – Sentri7 is deemed the market leading Clinical Decision Support – Surveillance solution out-performing competitive products by Premier Theradoc, CareFusion and Truven Health Micromedex.
Sentri7 was awarded top honors for exceptional:
92% would buy again (image)
“Wolters Kluwer is a very good company with excellent industry knowledge. Their people are responsive and take pride in the quality of service they provide to the end users. They keep the Sentri7 database current and up to date, which is critical for the software to be effective.” Director, March 2015
85% rated moderate to significant impact on clinical outcomes (image
“…Our clinical people can quickly and easily keep up with the patients that we are following. In addition, this system has excellent intervention data that is easy to access and allows us to present reports to management on our progress. This is a very valuable tool that we use extensively.” Director, March 2015
“Sentri7 has the flexibility to pull all the clinical data we need to make day-to-day decisions about patients” Director, May 2015
“Sentri7 is a very good tool. Wolters Kluwer has good products that work.” CIO, April 2015
An easily customizable, robust and flexible system Sentri7 requires little user training and minimal IT involvement.
“The customization is what we have found to be the most beneficial to our team. It definitely helps our workflow and helps us achieve more with the time we are given.” Analyst, October 2015.
“It is easy to build rules and it is very easy for the staff to use. The system creates a number of efficiencies for our staff and opportunities for intervention.” – VP/ executive, September 2015
KLAS interviewed EMR customers on current EMR-based surveillance. Allscripts, Cerner and Epic customers reported having few prebuilt rules and a very intensive customization process requiring IT resources and extensive training.”
“Sentri7 is an excellent system. It is flexible, and we can tweak it according to our needs. We don’t have to wait for somebody to write our rules for us because we can make our own rules.” Director, November 2015.
(Selected Commentary Above Collected about Sentri7 by KLAS in March 2015-October 2015 respectively @KLAS Enterprises, LLC. All rights reserved. To see a complete view visit www.KLASResearch.com)
2015/2016 Best in KLAS: Software and Services Report; January 2016
CDS Surveillance 2013: Impacting Outcomes; August 2013
Written for clinicians